The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

Professor of European public health at the London School of Hygiene and Tropical Medicine, Martin McKee, told the BBC the ...

Other countries, including the UK, have set out plans for booster campaigns that include vaccine mixing, with some experts arguing this could improve efficacy. Pfizer and BioNTech had hoped to get ...

The phase 2 trial will test a 30 µg dose of the shot in around 200 adult volunteers in the US who have already received one booster dose at least 90 days before enrolment, said Pfizer.

The new COVID vaccine is here, but does it bring any new side effects or reactions? Here's what the COVID booster 2024 side ...

Ticker: Free flu, COVID vaccines available across Boston; Cardinal O’Malley authorizes hurricane relief collection ...

After hours: October 18 at 7:59 PM EDT Loading Chart for PFE ...

The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The respiratory syncytial virus (RSV) vaccine (Abrysvo) was linked with fewer hospitalizations and emergency department (ED) ...